SENSEX NIFTY
Nath Bio-Genes Quarterly Results, Nath Bio-Genes Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Nath Bio-Genes
Nath Bio-Genes
BSE: 537291|NSE: NATHBIOGEN|ISIN: INE448G01010|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 10, 16:30
131.95
2.8 (2.17%)
VOLUME 7,759
LIVE
NSE
Dec 10, 16:30
132.00
3 (2.33%)
VOLUME 3,797

Quarterly Results of Nath Bio-Genes

------------------- in Rs. Cr. -------------------
Sep '14 Jun '14 Mar '14 Dec '13 Sep '13
Net Sales/Income from operations 30.06 119.47 40.37 26.24 19.50
Other Operating Income -- -- -- -- --
Total Income From Operations 30.06 119.47 40.37 26.24 19.50
EXPENDITURE
Consumption of Raw Materials 11.69 50.26 24.96 13.99 0.93
Purchase of Traded Goods -- -- -- -- --
Increase/Decrease in Stocks 3.45 -5.99 -13.56 -6.84 -7.74
Power & Fuel -- -- -- -- --
Employees Cost 2.47 3.80 5.22 2.09 2.87
Depreciation 1.10 1.10 0.91 1.25 1.25
Excise Duty -- -- -- -- --
Admin. And Selling Expenses 3.85 33.46 22.83 9.38 18.38
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 4.74 5.71 2.34 1.58 1.11
P/L Before Other Inc. , Int., Excpt. Items & Tax 2.77 31.13 -2.33 4.79 2.70
Other Income 0.07 0.04 0.34 0.10 0.09
P/L Before Int., Excpt. Items & Tax 2.85 31.17 -2.00 4.89 2.79
Interest 1.84 0.96 0.89 1.48 0.69
P/L Before Exceptional Items & Tax 1.01 30.21 -2.89 3.41 2.10
Exceptional Items 0.00 -- -- -- --
P/L Before Tax 1.01 30.21 -2.89 3.41 2.10
Tax -- -- 1.21 -- --
P/L After Tax from Ordinary Activities 1.01 30.21 -4.09 3.41 2.10
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -0.01 0.00 --
Net Profit/(Loss) For the Period 1.01 30.21 -4.10 3.40 2.10
Equity Share Capital 16.00 16.00 16.00 16.00 16.00
Reserves Excluding Revaluation Reserves 96.00 95.99 65.77 69.88 66.47
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 0.83 18.88 -2.56 2.13 1.31
Diluted EPS 0.83 18.88 -2.56 2.13 1.31
EPS After Extra Ordinary
Basic EPS 0.83 18.88 -2.56 2.13 1.31
Diluted EPS 0.83 18.88 -2.56 2.13 1.31
Public Share Holding
No Of Shares (Crores) 0.84 0.83 0.83 0.84 0.84
Share Holding (%) 52.35 51.79 51.79 52.18 52.18
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) 0.44 0.43 0.43 0.06 0.06
- Per. of shares (as a % of the total sh. of prom. and promoter group) 57.97 56.00 56.00 8.42 8.42
- Per. of shares (as a % of the total Share Cap. of the company) 27.62 27.00 27.00 4.03 4.03
b) Non-encumbered
- Number of shares (Crores) 0.32 0.34 0.34 0.70 0.70
- Per. of shares (as a % of the total sh. of prom. and promoter group) 42.03 44.00 44.00 91.58 91.58
- Per. of shares (as a % of the total Share Cap. of the company) 20.03 21.21 21.21 43.79 43.79
Notes Notes To The Accounts
Source : Dion Global Solutions Limited

Results of Nath Bio-Genes

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for nathbiogenes
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.